We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’s Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA. Teva Pharmaceutical Industries Limited's share was trading at $20.21 as of October 8th. TEVA’s trailing and forward P/E were 872.00 and 7.06 respectively according to Yahoo Finance.
Teva Pharmaceutical Industries (TEVA) is emerging as a compelling turnaround story, transitioning from a debt-laden generics player to a focused branded and specialty company with momentum in neuroscience. Market activity...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.